Biological characterization of MLN944: a potent DNA binding agent.
about
DNA Recognition by a Novel Bis-Intercalator, Potent Anticancer Drug XR5944Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalatorThe solution structure of bis(phenazine-1-carboxamide)-DNA complexes: MLN 944 binding corrected and extendedMetabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes.RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.Evaluating the genotoxicity of topoisomerase-targeted antibioticsMode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action.Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell linesRapid and automated multidimensional fluorescence microscopy profiling of 3D human breast culturesThe solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity.beta1 integrin as a molecular therapeutic target.Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy.Phenazines and cancer.DNA Interaction Studies of Selected Polyamine Conjugates.Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.Topical Fibronectin Improves Wound Healing of Irradiated SkinNovel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug.Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases.Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.An overview of recent advances in duplex DNA recognition by small molecules.
P2860
Q26991720-95257A07-1A66-4C2D-8919-36BD20539690Q27683071-3E154EB3-362F-4EEB-8C47-2F0B3CCE7193Q27690656-49F2291A-2706-4485-92DA-68DC87DB4097Q33805131-8A593536-7086-416E-8EF9-4BE04801898AQ34079523-467CE804-6F60-41B9-AB71-668A3CC2ACE8Q34095957-303DBFF2-BEFD-496E-8F56-304EF5978F44Q35691408-2E9B00BD-ED29-408D-B627-819C8E270A01Q36611220-7CC699B2-BDAE-4F32-BE5A-58C2D6ED9F22Q36616217-FB3719BF-DF00-4934-BBE3-E24664B17432Q36811016-6B0D9FE6-47C1-4E5A-B580-B28DE324F47DQ37021087-60835DA7-E135-4527-8153-ACEE4775EC08Q37024021-EB2612F6-947C-487E-B1AB-D189F33900FDQ37319785-FCDA662F-DB80-4365-9C95-D3CC5F22BC13Q37391029-9A133061-F1DE-49DD-88A3-8616C9B15B05Q37984218-C55FBCF3-E16A-498B-B13B-2AFDC3678E21Q38290849-6149F38F-CE07-4A9E-92FC-FAB13AA63F50Q38857006-79A7B066-C017-4BF4-8231-A2E323EDEDD6Q41081313-C81A5250-7F7A-4835-AFFC-626AEB8E3834Q45022876-B4414D88-5978-4995-AC93-A0C13C25526BQ46446314-185551EA-6CD8-47E0-8CB2-A583D9287A4DQ50094268-4CCCDD6B-CFF7-429B-AFB4-F851CB668CC0Q55476273-158B079F-AA7F-40E5-A852-393BD28A27D8
P2860
Biological characterization of MLN944: a potent DNA binding agent.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biological characterization of MLN944: a potent DNA binding agent.
@en
type
label
Biological characterization of MLN944: a potent DNA binding agent.
@en
prefLabel
Biological characterization of MLN944: a potent DNA binding agent.
@en
P2093
P356
P1476
Biological characterization of MLN944: a potent DNA binding agent.
@en
P2093
A Kathleen McClendon
Christine E Bulawa
Corinne Reimer
Darshan S Sappal
James A Fleming
Kelly Connolly
Laura A Rudolph-Owen
Neil Osheroff
Peter Charlton
Ronald K Blackman
P356
10.4161/CBT.3.1.570
P577
2004-01-01T00:00:00Z